. Author manuscript; available in PMC: 2019 May 1.

Published in final edited form as: Alzheimers Dement. 2017 Dec 20;14(5):623–633. doi: 10.1016/j.jalz.2017.11.006

Table 3.

Summary statistics of association between expression levels of the genes (MTUS1 and C14orf79) and AD status as well as Braak Stage.

Source	Brain region	Predictor	MTUS1			C14orf79
Source	Brain region	Predictor	β	SE	P	β	SE	P
Eisai Bio Bank (RNA-Seq)	HIPP	AD Status	0.38	0.16	0.02	0.04	0.14	0.76
Eisai Bio Bank (RNA-Seq)	HIPP	Braak Stages	0.16	0.04	3.9×10⁻⁴	−0.07	0.03	0.06

Mt. Sinai Hospital (Microarray)	CER	AD Status	0.00	0.02	0.78	−0.13	0.02	7.5×10⁻⁸
	DLPFC	AD Status	0.09	0.04	0.01	−0.13	0.02	3.3×10⁻⁷
	VCX	AD Status	0.09	0.03	0.01	−0.15	0.03	2.1×10⁻⁸

Brain regions tested were hippocampus (HIPP), cerebellum (CER), dorsolateral prefontal cortex (DLPFC), visual cortex (VCX). Positive effect (β) for AD status means that a gene is up-regulated in AD cases vs. in controls. Positive effect for Braak stages means that the expression of a gene is positively correlated with the Braak stages.